Key facts
- Analogic’s last known valuation is $1.1B (Jun 2018).
- It has raised $39.3M; the latest was PE Growth/Expansion in Aug 2025.
- Notable investors include Virginia Innovation Partnership Corporation, The Carlyle Group, Altaris.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Analogic
- ·The full record, as it builds
Funding rounds
No funding rounds for Analogic are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Analogic
Developer of healthcare and security technology designed for clinical testing. The company offers advanced imaging and real-time guidance technologies used for disease diagnosis and treatment, as well as for automated threat detection, thereby improving health and enhancing the safety of people around the world.
- Sector
- Healthcare
- HQ
- Peabody, MA, United States
- Founded
- 1967
- Employees
- 900
- Website
- analogic.com/
- Ownership
- Privately Held (backing)
Analogic doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Analogic shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Analogic in its N-PORT filings yet. We sweep new filings monthly.